Thus, the aim of this pilot study was to explore the utility of [68Ga]Ga-Pentixafor in patients with cancer of the head and neck and to compare this novel tracer with [18F]F-FDG on PET/CT imaging as well as CXCR4 immunohistochemistry staining. The gene discussed is CXCR4; the disease is cancer.